Current Assets
Allowance for Doubtful Accounts Receivable (Current)
Moderna Allowance for Doubtful Accounts Receivable (Current) increased by 100.0% to $6M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2024
Last reportedQ1 2026May 1, 2026
Metric ID:
allowance_for_doubtful_accounts_receivable_currentHistorical Data
5 periods
| Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $0 | $12M | $3M | $3M | $6M |
| QoQ Change | — | — | -75.0% | +0.0% | +100.0% |
Range$0 – $12M
Current Streak2 quarters growth
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Moderna's allowance for doubtful accounts receivable (current)?
- Moderna (MRNA) reported allowance for doubtful accounts receivable (current) of $6M in Q1 2026.